Dopaminergic function and the cortisol response to dexamethasone in psychotic depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 24, Issue 2, 2000, Pages 207-225

  Duval, Fabrice ^a   Mokrani, Marie Claude ^b   Crocq, Marc Antoine ^a   Bailey, Paul E ^b   Diep, Than S ^a   Correa, Humberto ^a   Macher, Jean Paul ^a  

^a Centre Hospitalier de Rouffach   (France)

^b Inst for Res in Neurosci in P   (France)

Author keywords

Apomorphine test; Cortisol; Depression; Dexamethasone suppression test; Dopamine; Psychotic disorders

Indexed keywords

APOMORPHINE; CORTICOTROPIN; DEXAMETHASONE; DOPAMINE RECEPTOR; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; ENDOCRINE FUNCTION; FEMALE; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PARANOID SCHIZOPHRENIA;

ADMINISTRATION, ORAL; ADULT; DEPRESSIVE DISORDER; DEXAMETHASONE; DOPAMINE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE;

EID: 0034144591     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(99)00098-6     Document Type: Article

References (63)

1. Aberg-Widtedt, A., Witedt, B. and Bertilsson, L. (1985): Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression. Arch Gen Psychiatry 42:925-926
2. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Washington, DC: American Psychiatric Press, pp 317-391.
3. Ansseau, M., Scheyvaerts, M., Doumont, A., Poirrier, R., Legros, J.J. and Franck, G. (1984): Concurrent use of REM latency, dexamethasone suppression, clonidine, and apomorphine tests as biological markers of endogenous depression: a pilot study. Psychiatry Res 12:261-272
4. Ansseau, M., Von Fraenckell, R., Cerfontaine, J.L., Papart, P., Franck, G., Timsit-Berthier, M., Greenen, V. and Legros, J.J. (1988): Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. Br J Psychiatry 153:65-71
5. Apa Task Force On Laboratory Tests (1987): The dexamethasone suppression test: an overview of its current status in psychiatry. Am J Psychiatry 14:1253-1262
6. Bird, E.D. (1984): Dexamethasone increases plasma free dopamine in man. J Psychiatr Res 18:217-223
7. Bjerkensstedt, L., Edmnan, G., Hagenfeldt, L., Sedvall, G. and Wiesel, F.A. (1985): Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. Br J Psychiatry 147:276-282
8. Carroll, B.J., Curtis, G.C. and Mendels, J. (1976): Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 33:1039-1044
9. Carroll, B.J., Greden,. J.F., Feinberg, M., James, N.M., Haskett, R.F., Steiner, M. and Tarika, J. (1980): Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression. Psychiatry Res 2:251-258
10. Carroll, B.J., Feinberg, M., Greden, J.F., Tarika, J., Albala, A.A., Hasket, R.F., James, N.M., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J.P. and Young, E. (1981). A specific laboratory test for the diagnosis of melancholia: standardisation, validation, and clinical utility. Arch Gen Psychiatry 38:15-22
11. Curet, O., Dennis, T. and Scatton, B. (1985): Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37:333-364
12. Devanand, D.P., Bowers, M.B., Hoffman, F.J. and Nelson, J.C. (1985): Elevated plasma homovanillic acid in depressed females with melancholia and psychosis. Psychiatr Res 15:1-4
13. Evans, D.L. and Nemeroff, C.B. (1987): The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis. J Psychiatry Res 21:185-194
14. Favre, R., de Haut, M., Dalmaz, J.M., Pequignot, J.M. and Peyrin, L. (1986): Peripheral distribution of free dopamine and its metabolites in the rat. J Neural Transm 66:135-149
15. Gatti, F., Bellini, L., Gasperini, M., Perez, J., Zanardi, R. and Smeraldi, E. (1996): Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry 153:414-416
16. Gormley, G.J., Lowy, M.T., Reder, A.T., Hospelhorn, V.G., Antel, J.P. and Meltzer, H.Y. (1985): Glucocorticoid receptors in depression: Relationship to the dexamethasone suppression test. Am J Psychiatry 142:1278-1284
17. Hamilton, M.A. (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
18. Holsboer, F., Von Bardeleben, U., Wiedeman, K., Müller, O.A. and Stalla, G.K. (1987): Serial assessment of cortico-releasing hormone response after dexamethasone in depression. Biol Psychiatry 22:228-234
19. Jezova, D. and Vigas, M. (1989): Apomorphine injection stimulates b-endorphine, adrenocorticotropin, and cortisol release in healthy man. Psychoneuroendocrinology 13:479-485
20. Kahn, R.S. and Davis, K.L. (1995): New developments in dopamine and schizophrenia. In: Psychopharmacology: The Fourth Generation of Progress, F.E. Bloom, D.J. Kupfer (Eds.), pp 1193-1203, Raven Press, New York.
21. Kathol, R.G., Jaeckle, R.S., Lopez, J.F. and Meller, W.H. (1989): Pathophysiology of HPA axis abnormalities in patients with major depression: an update. Am J Psychiatry 146:311-317
22. Kopin, I.J. (1985): Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37:333-364
23. Lal, S. (1987): Growth hormone and schizophrenia. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY (Ed), pp 809-818, Raven Press, New York.
24. Lal, S. (1988): Apomorphine in the evaluation of dopaminergic function in man. Prog Neuro-Psychopharmacol Biol Psychiatry 12:117-164
25. Lee, M. and Meltzer, H.Y. (1998): Effect of apomorphine on plasma cortisol in schizophrenia. Biol Psychiatry 43:133S
26. 3H] hydroxy-N, N di N-propyl-2-aminotetralin. Proc Natl Acad Sci USA 89:8155-8159
27. Levy, A.B. and Stern, S.L. (1987): DST and TRH stimulation test in mood disorder subtypes. Am J Psychiatry 144:472-475
28. Lupien, S., Richter, R., Risch, S.C., Mirow, A., Gillin, J.C. and Hauger, R.L. (1995): Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethasone administration. Psychiatry Res 58:23-35
29. Lu, R.B., Ho, S.L., Ho, B.T., Leu, S.Y., Shian, L.R. and Chen, W.L. (1986): Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone nonsuppressors. J Affect Disord 10:177-184
30. Maas, J.W., Contreras, S.A., Seleshi, E. and Bowden, C.L. (1988): Dopamine metabolism and disposition in schizophrenic patients. Arch Gen Psychiarty 45:553-559
31. Mazure, C.M., Bowers, M.B., Hoffman, F., Miller, K.B. and Nelson, J.C. (1987): Plasma catecholamine metabolites in subtype of major depression. Biol Psychiat 22:1469-1472
32. Meltzer, H.Y., Kolakowska, T., Fang, V.S., Fogg, L., Robertson, A., Lewine, R., Strahilevitz, M. and Busch, D. (1984): Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Arch Gen Psychiatry 41:512-519
33. Metz, C.E. (1978): Basic principles of ROC analysis. Semin Nucl Med 8:283-298
34. Mokrani, M.C., Duval, F., Crocq, M.A., Bailey, P.E. and Macher, J.P. (1995): Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology 20:365-375
35. Nelson, J.C. and Davis, J.M. (1997): DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 154:1497-1503.
36. Overall, J.E. and Gorman, D.R. (1962): The Brief Psychiatric Rating Scale. Psychol Rep 10:799-812
37. Piazza, P.V., Rouge-Pont, F., Deroche, V., Maccarri, S., Simon, H. and Le Moal, M. (1996): Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic dopaminergic transmission. Proc Natl Acad Sci 93:8716-8720
38. Pitchot, W., Hansenne, M., Gonzales Moreno, A. and Ansseau, M. (1992): Suicidal behavior and growth hormone response to apomorphine test. Biol Psychiatry 31:1213-1219
39. Posener, J.A., Schildkraut, J.J., Williams, G.H., Gleason, R.E., Salomon, M.S., Mecheri, G. and Schatzberg, A.F. (1994): Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man. Biol Psychiatry 36:616-621
40. Posener, J.A., Schildkraut, J.J., Samson, J.A. and Schatzberg, A.F. (1996): Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects. Psychoneuroendocrinology 21:33-38
41. Posener, J.A., Schatzberg, A.F., Williams, G.H., Samson, J.A., Mc Hale, N.L., Bessette, M.P. and Schildkraut, J.J. (1999): Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man. Biol Psychiatry 45:222-228
42. Reus, V.I., Wolkowitz, O.M. and Frederick, S. (1997): Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology 22:S121-124
43. Rihmer, Z., Arato, M., Szadoczyk, E., Revai, K., Demeter, E., Gyorgy, S. and Udvarhelyi, P. (1984): The dexamethasone suppression test in psychotic versus nonpsychotic endogenous depression. Br J Psychiatry 145:508-511
44. Rubin, R.T. (1987): Prolactin and schizophrenia. In: Psychopharmacology: The Third Generation of Progress, Meltzer HY (Ed), pp 803-808, Raven Press, New York.
45. Rudorfer, M.V., Hwu, H.G. and Clayton, P.J. (1982): Dexamethasone suppression testing in primary depression: significance of family history and psychosis. Biol Psychiatry 17:41-48
46. Rotschild, A.J., Langlais, P.J., Schatzberg, A.F., Walsh, F.X., Cole, J.O. and Bird, E.D. (1984): Dexamethasone increases plasma free dopamine in man. J Psychiatr Res 18:217-223
47. Rotschild, A.J., Langlais, P.J., Schatzberg, A.F., Miller, M.M., Saloman, M.S., Lerbinger, J.E., Cole, J.O. and Bird, E.D. (1985): The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci 36:2491-2501
48. Rotschild, A.J., Schatzberg, A.F., Langlais, P.J., Lerbinger, J.E., Miller, M.M. and Cole, J.O. (1987): Psychotic and nonpsychotic depressions, I: comparison of plasma catecholamines and cortisol measures. Psychiatry Res 20:143-153
49. Rupprecht, R., Rupprecht, M., Rupprecht, C., Sofic, E., Barocka, A., Beck, G., Noder, M. and Riederer, P. (1989): Effects of glucocorticoids on plasma catecholamine in depression. Psychiatry Res 29:187-198
50. Schatzberg, A.F., Rotschild, A.J., Langlais, P.J., Bird, E.D. and Cole, J.O. (1985): A corticoid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res 19:57-64
51. Schatzberg, A.F. and Rotschild, A.J. (1992) Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV. Am J Psychiatry 149:733-745
52. Sweeney, D., Nelson, C., Bowers, M., Mass, J. and Heninger, G. (1978): Delusionnal versus nondelusionnal depression: Neurochemical differences. Lancet 2:100-101
53. Syvälahti, E. (1985): Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in-and outpatients. Acta Psychiatr Scand 71:105-110
54. Tuomisto, J. and Männistö, P. (1985): Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37:249-332
55. Van Praag, H.M., Korf, J., Lakke, J.P.W.F. and Schut, T. (1975): Dopamine metabolism in depression, psychoses, and Parkinson's disease: the problem of specificity of biological variables in behavior disorders. Psychol Med 5:138-146
56. Wieselgren, I.M. and Lindström, L.H. (1998): CSF levels of HVA and 5-HIAA in drug free schizophrenic patients and healthy controls: a prospective study focused on their predictive value for outcome in schizophrenia. Psychiatry Res 81:101-110
57. Wolkowitz, O.M., Sutton, M.E., Doran, A.R., Labarca, R., Roy, A,. Thomas, J.W., Pickar, D. and Paul, S.M. (1985): Dexamethasone increases plasma HVA but not MHPG in normal humans. Psychiatry Res 16:101-109
58. Wolkowitz, O.M., Sutton, M., Koulu, M., Labaraca, R., Wilkinson, L., Doran, A., Hauger, R., Pickar, D. and Crawley, J. (1986): Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity. Eur J Pharmacol 122:329-338
59. Wolkowitz, O.M., Doran, A.R., Breier, A., Jimerson, D.C., Sutton, M.E., Golden, R.N., Paul, S.M. and Pickar, D. (1987): The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression. Arch Gen Psychiatry 44:782-789
60. Wolkowitz, O.M., Doran, A., Breier, A., Roy, A. and Pickar, D. (1989): Specificity of plasma HVA response to dexamethasone in psychotic depression. Psychiatry Res 29:177-186
61. Young, E.A., Kotum, J., Haskett, R.F., Grunhaus, L., Greden, J.F., Watson, S.J. and Akil, H. (1993): Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch Gen Psychiatry 50:395-403
62. Zanardi, R., Franchini, L., Gasperini, M., Perez, J. and Smeraldi, E. (1996): Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry 153:1631-1633
63. Zanardi, R., Franchini, L., Gasperini, M., Perez, J. and Smeraldi, E. (1998): Selective serotonin inhibitors alone and in association with pindolol in the treatment of delusional depression. Eur Neuropsychopharmacol 8:S98